HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knapp, K. K. Articles by Miller, L. M. Search for Related Content PubMed PubMed Citation Articles by Knapp, K. K. Articles by Miller, L. M.

KATHERINE K. KNAPP, PH.D., is Dean, College of Pharmacy, Touro University—California, Vallejo; when this project was conducted, she was Professor and Director, Center for Pharmacy Practice Research and Development, College of Pharmacy, Western University of Health Sciences (WUHS), Pomona, CA. RYAN M. QUIST, PH.D., is Research Associate, College of Pharmacy, WUHS. SURREY M. WALTON, PH.D., is Assistant Professor of Pharmacy Administration, College of Pharmacy, University of Illinois at Chicago, Chicago. LAURA M. MILLER, PH.D., is Senior Economist, National Association of Chain Drug Stores, Alexandria, VA.

Address correspondence to Dr. Knapp at the College of Pharmacy, Touro University—California, 1310 Johnson Lane, Mare Island, Vallejo, CA 94592.

Purpose. Aggregate Demand Index (ADI) survey results were used to describe the severity of the pharmacist shortage at the national and state levels and by practice site and impact on the U.S. population. Methods. Time-series analysis was used to characterize national and state trends in the ADI from September 1999 through September 2003. The time trends for the distribution of ratings and the demand index by practice site were also examined. Historical data about retail prescriptions filled and related growth rates were compiled and compared. ADI survey results were also compared with data from other surveys. Results. Over time, ADI data demonstrated a continuing national pharmacist shortage, as the ability to fill pharmacist vacancies was rated at least moderately difficult. A very slight downward trend in severity (slope = –0.008) was observed. Other survey series had similar findings. States with the most severe shortage levels tended to have large populations, while those with the lowest levels tended to have smaller populations. More states improved than worsened the severity of their shortage, with 30 states maintaining the same ADI rating. Although there was a high correlation between the retail prescription growth rate and the ADI (r = 0.84), there was a much greater decrease in prescription growth (73%) than ADI levels (6.5%). Conclusion. There was a sustained unmet demand for pharmacists throughout the United States from September 1999 through September 2003. More states moved toward having an adequate supply of pharmacists than toward having a more severe shortage of pharmacists, but the national ADI suggests that the system remains stressed. Index terms: Data collection; Employment; Manpower; Pharmacists; Prescriptions; United States

 

This article has been cited by other articles:

				K. Hassell, L. Nichols, and P. Noyce Part of a global workforce: migration of British-trained pharmacists J Health Serv Res Policy, April 1, 2008; 13(suppl_2): 32 - 39. [Abstract] [Full Text] [PDF]

				ASHP Statement on Professionalism Am. J. Health Syst. Pharm., January 15, 2008; 65(2): 172 - 174. [Full Text] [PDF]

				L. C. Vermeulen, S. S. Rough, T. S. Thielke, R. R. Shane, M. F. Ivey, B. W. Woodward, P. G. Pierpaoli, S. M. Thomley, C. A. Borr, and D. A. Zilz Strategic approach for improving the medication-use process in health systems: The high-performance pharmacy practice framework Am. J. Health Syst. Pharm., August 15, 2007; 64(16): 1699 - 1710. [Abstract] [Full Text] [PDF]

				A. D. Tice, R. S. Turpin, C. T. Hoey, B. A. Lipsky, J. Wu, and M. A. Abramson Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections Am. J. Health Syst. Pharm., May 15, 2007; 64(10): 1080 - 1086. [Abstract] [Full Text] [PDF]

				C. A. Pedersen, P. J. Schneider, and D. J. Scheckelhoff ASHP national survey of pharmacy practice in hospital settings: Monitoring and patient education--2006 Am. J. Health Syst. Pharm., March 1, 2007; 64(5): 507 - 520. [Abstract] [Full Text] [PDF]